Bibliometric Mapping of Mesenchymal Stem Cell Therapy for Bone Regeneration from 2013 to 2023

Overview

Journal Front Med (Lausanne)

Date 2025 Jan 21

PMID 39835103

Authors

Qianqian Chen

Yiqi Su

Zhen Yang

Qiyuan Lin

Yan Ke

Dan Xing

Hui Li

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSCs) have shown significant potential in bone regeneration and regenerative medicine in recent years. With the advancement of tissue engineering, MSCs have been increasingly applied in bone repair and regeneration, and their clinical application potential has grown through interdisciplinary approaches involving biomaterials and genetic engineering. However, there is a lack of systematic reviews summarizing their applications in bone regeneration. To address this gap, we analyzed the latest research on MSCs for bone regeneration published from 2013 to 2023. Using the Web of Science Core Collection, we conducted a literature search in December 2024 and employed bibliometric tools like CiteSpace and VOSviewer for a comprehensive analysis of the key research trends. Our findings focus on the development of cell engineering, highlighting the advantages, limitations, and future prospects of MSC applications in bone regeneration. These insights aim to enhance understanding of MSC-based bone regeneration, inspire new research directions, and facilitate the clinical translation of MSC research.

References

English K . Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol. 2012; 91(1):19-26. DOI: 10.1038/icb.2012.56. View

Roche E, Hastings C, Lewin S, Shvartsman D, Brudno Y, Vasilyev N . Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. Biomaterials. 2014; 35(25):6850-6858. PMC: 4051834. DOI: 10.1016/j.biomaterials.2014.04.114. View

Zhang B, Yang L, Zeng Z, Feng Y, Wang X, Wu X . Leptin Potentiates BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Through the Activation of JAK/STAT Signaling. Stem Cells Dev. 2020; 29(8):498-510. PMC: 7153647. DOI: 10.1089/scd.2019.0292. View

Spaggiari G, Capobianco A, Becchetti S, Mingari M, Moretta L . Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood. 2005; 107(4):1484-90. DOI: 10.1182/blood-2005-07-2775. View

Bianchi G, Borgonovo G, Pistoia V, Raffaghello L . Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells. Histol Histopathol. 2011; 26(7):941-51. DOI: 10.14670/HH-26.941. View

Yao Z, Yang Y, Kong J, Zhu Y, Li L, Chang C . Biostimulatory Micro-Fragmented Nanofiber-Hydrogel Composite Improves Mesenchymal Stem Cell Delivery and Soft Tissue Remodeling. Small. 2022; 18(36):e2202309. PMC: 9994419. DOI: 10.1002/smll.202202309. View

Wong J, Mehta A, Vu T, Yeo G . Cellular modifications and biomaterial design to improve mesenchymal stem cell transplantation. Biomater Sci. 2023; 11(14):4752-4773. DOI: 10.1039/d3bm00376k. View

Krauskopf E . A bibiliometric analysis of the Journal of Infection and Public Health: 2008-2016. J Infect Public Health. 2018; 11(2):224-229. DOI: 10.1016/j.jiph.2017.12.011. View

Aronson J . Limb-lengthening, skeletal reconstruction, and bone transport with the Ilizarov method. J Bone Joint Surg Am. 1997; 79(8):1243-58. DOI: 10.2106/00004623-199708000-00019. View

10.

Ullah I, Subbarao R, Rho G . Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015; 35(2). PMC: 4413017. DOI: 10.1042/BSR20150025. View

11.

Ahmed L, Al-Massri K . Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives. Curr Stem Cell Res Ther. 2021; 16(7):858-876. DOI: 10.2174/1574888X16666210303151237. View

12.

Synnestvedt M, Chen C, Holmes J . CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2006; :724-8. PMC: 1560567. View

13.

Wei X, Yang X, Han Z, Qu F, Shao L, Shi Y . Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013; 34(6):747-54. PMC: 4002895. DOI: 10.1038/aps.2013.50. View

14.

Xu Z, Wang B, Huang R, Guo M, Han D, Yin L . Efforts to promote osteogenesis-angiogenesis coupling for bone tissue engineering. Biomater Sci. 2024; 12(11):2801-2830. DOI: 10.1039/d3bm02017g. View

15.

Aspenberg P, Sandberg O . Distal radial fractures heal by direct woven bone formation. Acta Orthop. 2013; 84(3):297-300. PMC: 3715812. DOI: 10.3109/17453674.2013.792769. View

16.

Kim J, Hematti P . Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol. 2009; 37(12):1445-53. PMC: 2783735. DOI: 10.1016/j.exphem.2009.09.004. View

17.

Squillaro T, Peluso G, Galderisi U . Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplant. 2015; 25(5):829-48. DOI: 10.3727/096368915X689622. View

18.

Prockop D . Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997; 276(5309):71-4. DOI: 10.1126/science.276.5309.71. View

19.

FRIEDENSTEIN A, PETRAKOVA K . Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966; 16(3):381-90. View

20.

Chen F, Tuan R . Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008; 10(5):223. PMC: 2592798. DOI: 10.1186/ar2514. View